The news story you are looking for has expired. A more recent related article is displayed below.

Sponsored Links

Cohen Independent Research Group Publishes Nutra Pharma Profile

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced that Cohen Independent Research Group has published a report profiling Nutra Pharma Corp.

The report, which was commissioned by Nutra Pharma, focuses on the company's current drug development initiatives, including the company's leading drug candidates for the treatment of Multiple Sclerosis (MS), HIV, Adrenomyeloneuropathy (AMN), and Rheumatoid Arthritis (RA) as well as the company's recent launch of Cobroxin for the treatment of chronic pain, the Company noted in a release.

Report Information:

http://www.cohenresearch.com/reports/nphc_10-21-09.pdf

((Comments on this story may be sent to health@closeupmedia.com))

Copyright (C) 2009 Close-Up Media. All rights reserved

News Provided by COMTEX


Related terms: arthritis, biotechnology, health, hiv, research

Related Articles

Nutra Pharma Announces Publication of Research Report by Cohen Independent Research Group - Zibb.com
Oct 22, 2009
Nutra Pharma Announces Publication...Research Report by Cohen Independent Research Group Nutra Pharma Corp. (OTCBB: NPHC...AMN), HIV and Multiple Sclerosis (MS), has announced today that Cohen Independent Research Group has published...

Science & Technology
Nov 1, 2009
...A. Haley Veterans' Hosp., Tampa, FL Voices of Multiple Sclerosis: The Healing Companion; Stories for Courage, Comfort...contains inspiring true stories by those affected by multiple sclerosis (MS). Beginning with a medical overview, the book...

Practice Panel: professional comment on case of woman with physical and mental health issues
Oct 30, 2009
...Social workers advise on a case involving a woman with multiple sclerosis, tardive dyskinesia and schizophrenia with mobility problems...cottage owned by her mother. She has been diagnosed with multiple sclerosis and tardive dyskinesia, which involves involuntary...

Injected cells stop body from attacking self
Nov 3, 2009
...cells or T-regs, for their potential to treat autoimmune disorders such as rheumatoid arthritis, diabetes and multiple sclerosis. There have been two challenges: how to obtain large supplies of the rare T-regs, which make up less...